Present role and future perspectives of the evaluation of the effect of primary chemotherapy by breast imaging

被引：4

作者：

Nakamura S. ^{[1
]}

机构：

[1] Department of Surgery, St.Luke's International Hospital, Chuo-ku, Tokyo 104-0044

来源：

Breast Cancer | 2004年 / 11卷 / 2期

关键词：

3-D MRI; MDCT; PCR; PET; Primary chemotherapy;

D O I：

10.1007/BF02968292

中图分类号：

学科分类号：

摘要：

Recently, primary chemotherapy has been used not only for locally advanced breast cancers but also operable cases in an adjuvant setting. Therefore, many randomized clinical trials for primary chemotherapy have been coducted all over the world, with the result that more than one-third of the cases have become nonpalpable (clinical CR). On the contrary, accurate determination of the surgical margin has become more difficult. If some cancer remains as a nonpalpable lesion, it must be detected. Breast MRI has been assuming an important role in the assessment of the extent of cancer and does so more accurately than conventional modalifies such as mammography and ultrasonography. Image-guided biopsy or mapping is promising and should be developed as soon as possible. In this article, some promising modalities for the detection of residual lesions after primary chemotherapy are extensively reviewed. © Springer, Part of Springer Science+Business Media.

引用

页码：134 / 138

页数：4

共 32 条

[1]

Makris A., Powles T.J., Ashley S.E., Chang J., Hickish T., Tidy V.A., Nash A.G., Ford H.T., A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer, Annals of Oncology, 9, 11, pp. 1179-1184, (1998)

[2]

McMasters K.M., Hunt K.K., Neoadjuvant chemotherapy, locally advanced breast cancer, and quality of life, Journal of Clinical Oncology, 17, 2, pp. 441-444, (1999)

[3]

Valero V., Buzdar A.U., McNeese M., Singletary E., Hortobagyi G.N., Primary chemotherapy in the treatment of breast cancer: The University of Texas M.D. Anderson Cancer Center experience, Clin Breast Cancer, 3, SUPPL. 2, pp. 63-68, (2002)

[4]

Fisher B., Brown A., Mamounas E., Wieand S., Robidoux A., Margolese R.G., Cruz Jr. A.B., Fisher E.R., Wickerham D.L., Wolmark N., DeCillis A., Hoehn J.L., Lees A.W., Dimitrov N.V., Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: Findings from national surgical adjuvant breast and bowel project B-18, Journal of Clinical Oncology, 15, 7, pp. 2483-2493, (1997)

[5]

Fisher B., Bryant J., Wolmark N., Mamounas E., Brown A., Fisher E.R., Wickerham D.L., Begovic M., DeCillis A., Robidoux A., Margolese R.G., Cruz Jr. A.B., Hoehn J.L., Lees A.W., Dimitrov N.V., Bear H.D., Effect of preoperative chemotherapy on the outcome of women with operable breast cancer, Journal of Clinical Oncology, 16, 8, pp. 2672-2685, (1998)

[6]

Nakamura S., Kenjo H., Nishino T., Kazama T., Doi O., Suzuki K., 3D-MR mammography-gnided breast conserving surgery after neoadjuvant chemotherapy: Clinical results and future perspectives with reference to FDG-PET, Breast Cancer, 8, pp. 351-354, (2001)

[7]

Nakamura S., Kenjo H., Nishino T., Kazama T., Doi O., Suzuki K., Efficacy of 3D-mammography for breast conserving surgery after neoadjuvant chemotherapy, Breast Cancer, 9, pp. 15-19, (2002)

[8]

Mamounas E.P., Accuracy of sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: Updated results from NSABP B-27, Proc Am Soc Clin Oncol (ASCO), (2002)

[9]

Anscher M.S., Jones P., Prosnitz L.R., Blackstock W., Hebert M., Reddick R., Tucker A., Dodge R., Leight Jr. G., Iglehart J.D., Rosenman J., Local failure and margin status in early-stage breast carcinoma treated with conservation surgery and radiation therapy, Annals of Surgery, 218, 1, pp. 22-28, (1993)

[10]

Fortin A., Larochelle M., Laverdiere J., Lavertu S., Tremblay D., Local failure is responsible for the decrease in survival for patients with breast cancer treated with conservative surgery and postoperative radiotherapy, Journal of Clinical Oncology, 17, 1, pp. 101-109, (1999)

← 1 2 3 4 →